| Profile | GDS4177 / 218592_s_at |
| Title | Imatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1 |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM603100 | KU-812 Imatinib-treated | 195.57 | 79 |
| GSM603099 | KU-812 non-treated | 284.65 | 84 |
| GSM603098 | KCL-22 Imatinib-treated | 461.79 | 89 |
| GSM603097 | KCL-22 non-treated | 1085.96 | 95 |
| GSM603102 | JURL-MK1 Imatinib-treated | 262.04 | 83 |
| GSM603101 | JURL-MK1 non-treated | 359.3 | 86 |